跳至主要内容
临床试验/JPRN-C000000306
JPRN-C000000306已完成未知

Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Multicentric Phase II Study - Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Multicentric Phase II Study

Department of Otorhinolaryngology and Head and Neck Surgery, Osaka University School of Medicine0 个研究点目标入组 150 人开始时间: 2006年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

CR rate 71%, 2-year overall survival 82%, and 4-year overall survival 68% for technically resectable disease. CR rate 45%, 2-year overall survival 58%, and 4-year overall survival 44% for technically unresectable disease.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) interstitial pneumonia or pulmonary fibrosis evidenced by chest X-ray and/or chest CT 2) major heart/lung disorders, or uncontrolled diabetes mellitus 3) distant metastases or second primary cancer except when there has been no evidence of the disease for more than 24 months without any treatment and when the disease is superficial 4) major pulmonary effusion or ascites 5) neuropathy or edema 6) pregnancy or lactation 7) history of major allergy to medicine 8) long use of steroid

研究者

发起方
Department of Otorhinolaryngology and Head and Neck Surgery, Osaka University School of Medicine

相似试验